FDA panel narrowly backs multi-cancer blood test despite doubts it works

A blood test that aims to catch more than 50 types of cancer before symptoms appear narrowly won the backing of U.S. Food and ...
Becker's Hospital Review

FDA panel backs first multi-cancer blood test: What to know

FDA panel backs first multi-cancer blood test, Galleri, confirming safety and recommending continued routine screenings for adults 50 and older.

Largest Real-World Evidence Study in Early-Stage Breast Cancer; FLEX Surpasses 25,000 Patients

Agendia’s landmark FLEX Study reaches a major enrollment milestone, accelerating real-world insights to advance more personalized breast cancer care ...

F.D.A. Advisory Panel Endorses Controversial Cancer Blood Test

The panelists expressed reservations about the evidence supporting Grail’s Galleri test, which is designed to detect cancers ...

US FDA advisers endorse Grail cancer test's benefits in key vote

A panel of outside experts advising the US FDA said ​on Wednesday the benefits of Grail's blood-based cancer detection test outweigh ‌its risks, paving the way for a potential landmark approval in ...

FDA panel endorses first-of-a-kind cancer blood test from Grail

A blood test designed to spot signs of multiple cancers in apparently healthy people faces its first major regulatory hurdle ...
KPCW

FDA advisory panel recommends a first: multi-cancer blood test

The company Grail says its Galleri blood test can detect up to 50 forms of cancer. An independent panel of experts weighed ...